Magnesium and Sudden Death by Cardiac Arrest

[Guest guest]

Magnesium and Sudden Death by Cardiac Arrest

_http://naturalallopathiccardiology.com/cms/index.php?option=com_content & vie

w=article & id=112 & Itemid=149_

(http://naturalallopathiccardiology.com/cms/index.php?option=com_content & view=ar\

ticle & id=112 & Itemid=149)

 

 

Due to lack of magnesium the heart muscle can develop a spasm or cramp and

stops beating. Most people, including doctors, don’t know it but without

sufficient magnesium we will die. It is more than helpful to understand that

our life span will be reduced if we run too long without sufficient

magnesium in our cells and that the principle way our life is cut short is

through cardiac arrest. Yet when someone dies of a heart attack people never

say “

He died from Magnesium Deficiency.†Allopathic medicine is designed from

the bottom up which means it ignores the true causes of death and

disease. In the field of cardiology this is telling!

Magnesium deficiency appears to have caused

eight million sudden coronary deaths in America

during the period 1940-1994.[ii]

Paul Mason

It is established that clinically significant changes in a number of

electrolytes occur in patients with congestive heart failure (CHF). Magnesium

ions are an essential requirement for many enzyme systems, and clearly

magnesium deficiency is a major risk factor for survival of CHF patients. In

animal experiments, magnesium has been shown to be involved in several steps of

the atherosclerotic process as well as magnesium ions playing an extremely

important role in CHF and various cardiac arrhythmias.

Magnesium is an important protective factor for death

from acute myocardial infarction.[iii]

Dr. Jean Durlach[iv] explains that the body has numerous compensatory

mechanisms that allow magnesium deficiency to go undetected which leads to the

development of what he calls " latent nervous system hyperexcitability. " In

other words, a patient will already be deficient in magnesium prior to the

development of symptoms. Too often the first clear sign of deficiency is

cardiac arrest and death. Forty percent of all first heart attacks end in

death!

A ten-year study of 2,182 men in Wales found that those eating

magnesium-low diets had a 50% higher risk of sudden death from heart attacks

than

those eating one-third more magnesium. Also, high magnesium eaters were only

half as likely to have any type of cardiovascular incident such as non-fatal

heart attacks, strokes, angina (chest pain) or heart surgery.[v]

In 2003, a follow-up study of these same patients revealed an enduring

effect of magnesium treatment. Nearly twice as many patients in the standard

treatment group had died compared to those who received magnesium, and there

were considerably more cases of heart failure and impaired heart function

in the placebo group.

In addition to increasing survival after heart attack, IV magnesium also

smoothes out arrhythmias and improves outcomes in patients undergoing

angioplasty with stent placement. It is also beneficial for acute asthma

attacks,

often working to relax airway spasms when drugs do not. Magnesium

supplementation is crucial for diabetics, too, because it improves insulin

sensitivity, helps blood sugar control, and reduces risk of retinopathy.

Therapy with magnesium is rapid acting, has a safe toxic-therapeutic ratio

and is easy to administer and titrate.[vi] Magnesium is economical, widely

available and has a long established safety and tolerability profile in

myocardial infarction. Magnesium chloride has the advantage of being

administered intravenously, intramuscularly, and orally. It can also be

vaporized

through a nebulizer as well as a lotion transdermally. In anesthesia and

intensive care, the preferred administration route is IV.

Magnesium ions cross the intact blood-brain barrier efficaciously

so that intravenous magnesium significantly raises cerebrospinal fluid

and brain extracellular fluid magnesium levels quickly.

In the 90’s cardiovascular biologist Dr. Burton M. Altura of the State

University of New York Health Science Center at Brooklyn witnessed a

therapeutic benefit of magnesium in acute symptoms, such as headache pain.

Altura

administered a solution containing 1 gram of magnesium sulfate intravenously

to 40 patients who visited a headache clinic in the throes of moderate to

severe pain. They treated not only migraine sufferers but also persons with

cluster headaches and chronic daily headaches.

Within 15 minutes, 32 of the men and women—80 percent—experienced relief.

Though the headache may not have vanished, the pain lessened by at least

50 percent. In 18 of these individuals, the pain relief lasted at least 24

hours. Blood tests before treatment confirmed that all but four in this

latter group had ionized magnesium concentrations that were lower than the

average in a related group of pain free individuals. " All nine patients with

cluster headaches had their acute headache aborted by magnesium therapy. "

Migraine sufferers who responded to the treatment experienced a complete

alleviation of their current symptoms, including sensitivity to lights and

sound. Subsequent studies of additional migraine patients have confirmed a

common pattern. Altura says. " Those patients where ionized magnesium in the

brain or blood is low will respond to intravenous magnesium very quickly and

dramatically. "

The following chapter introduces transdermal medicine, an extraordinary

method of magnesium application that has not been studied by allopathic

medical science. This chapter focuses on western medicine’s experience with

intravenous magnesium infusions and injections. Doctors need to learn about and

use the wide spectrum of administration routes to harness the full

medicinal power of magnesium.

Heart palpitations, " flutters " or racing heart, otherwise called

arrhythmias,

usually clear up quite dramatically on 500 milligrams of magnesium citrate

(or aspartate) once or twice daily or faster if given intravenously.

Dr. H. Ray Evers

Magnesium has minimal side effects in usual therapeutic doses and has a

large therapeutic index. The timing and doses of magnesium are critical

especially in cases of stroke or heart failure. The Fast-Mag (Field

Administration of Stroke Therapy – Magnesium (FAST-MAG) trials are being

carried out in

Los Angeles to show the beneficial effects of early magnesium

administration by paramedics when stroke first occurs. Each year in the US,

over

750,000 Americans suffer a symptomatic stroke.

Magnesium chloride is first aid for the heart.

More than 4 out of 5 strokes are due to ischemic infarction.

The FAST-MAG trial was designed to address the crucial factor of delayed

time to treatment, which has hindered past human clinical trials of

neuroprotective drugs. Animal studies suggest the duration of the therapeutic

window is very brief, generally less than 2-3 hours. Most animal studies of

neuroprotective agents initiate therapy within 1-60 minutes after ischemia

onset. Because magnesium medicine is poorly understood by western medicine it

is rarely used early enough or often enough to benefit from its full

potential to save lives or reduce suffering among cardiac or stroke patients.

Cardiac arrhythmias and coronary artery vasospasm can be caused by

magnesium deficiency and intravenous magnesium reduces the risk of arrhythmia

and

death immediately after acute myocardial infarction.[vii]

References

Since the Rockefellers invaded the medical industry almost 100 years

ago we can see a deliberate pattern engineered into the foundation of

medicine. That engineering was and still is full of hate for human beings

meaning

it is full of love of money and power. Whenever you have money interests

take the place of humanitarianism in medicine you produce a form of medicine

that hurts and kills people.

[ii] _http://www.mgwater.com/calcs.shtml_

(http://www.mgwater.com/calcs.shtml)

[iii] Am J Epidemiol 1996;143:456–62.

[iv] President of the International Society for the Development of

Research on Magnesium (SDRM), and Editor-in Chief of Magnesium Research

[v] _http://www.mgwater.com/marxneut.shtml_

(http://www.mgwater.com/marxneut.shtml)

[vi] Crippa G, Sverzellati E, Giorgi-Pierfranceschi M, et al. Magnesium

and cardiovascular drugs: interactions and therapeutic role. Ann Ital Med

Int. 1999 Jan; 14(1):40-5.

[vii] Eisenberg MJ, Magnesium deficiency and sudden death (editorial), AM

Heart J 1992 Aug; 124(2):544-9

(http://www.papercut.biz/emailStripper.htm)